A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567.

Trial Identifier: D6470C00001
Sponsor: AstraZeneca
NCTID:: NCT02512575
Start Date: November 2015
Primary Completion Date: September 2016
Condition: Healthy Volunteers; Other; Rheumatoid Arthritis

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
German Translation

Trial Locations

Country Location
Germany Berlin, Germany, 14050